<Record>
<Term>Interleukin-1-beta New Formulation</Term>
<SemanticType>Pharmacologic Substance</SemanticType>
<ParentTerm>NCIThesaurus</ParentTerm>
<ClassificationPath>Interleukin-1-beta New Formulation</ClassificationPath>
<BroaderTerm>Interleukin-1-beta New Formulation</BroaderTerm>
<Synonym>IL-1 beta New Formulation</Synonym>
<Synonym>Interleukin-1-beta New Formulation</Synonym>
<Description>An aqueous therapeutic analogue of the endogenous cytokine interleukin-1-beta (IL-1-beta). Produced mainly by monocytes, endogenous IL-1-beta plays a role in hematopoiesis, is a potent stimulator of T-cell activity, and may promote or inhibit tumor growth, depending on tumor type. (NCI04)</Description>
<Source>NCI Thesaurus</Source>
</Record>
